WAYHealthcare · Health Information ServicesThe 24 Wall Street analysts covering Waystar Holding Corp. hold a median 12-month price target of $33 — +26.7% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 38 of 100 as at 2 Sept 2026 — in the lower half. The Street sees upside; the factor read is a caution. That gap is the story on this page.
Consensus tells you what everyone already believes. The model scores Waystar Holding Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Revisions (81): Analysts have, on balance, been raising their forecasts.
Issuance (19): The company has been issuing shares or taking on financing, diluting existing holders.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on WAY, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +26.7% from it.
Of the 20 most recent actions, 2 moved their price target up and 3 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 31 Aug 2026 | Canaccord Genuity | Maintains | Buy | $30 → $33 |
| 27 Aug 2026 | RBC Capital | Reiterates | Outperform | $44 |
| 26 Aug 2026 | Needham | Reiterates | Buy | $33 |
| 13 Aug 2026 | Truist Securities | Maintains | Buy | — |
| 13 Aug 2026 | Truist Securities | Maintains | Buy | $38 → $33 |
| 7 Aug 2026 | Barclays | Maintains | Overweight | — |
| 7 Aug 2026 | Barclays | Maintains | Overweight | $25 → $27 |
| 30 July 2026 | Needham | Reiterates | Buy | — |
| 30 July 2026 | Needham | Reiterates | Buy | $33 |
| 30 July 2026 | UBS | Maintains | Buy | $37 → $33 |
| 30 July 2026 | UBS | Maintains | Buy | — |
| 30 July 2026 | Wells Fargo | Maintains | Overweight | — |
| 30 July 2026 | Wells Fargo | Maintains | Overweight | $36 → $33 |
| 2 July 2026 | Keybanc | Initiates | Overweight | — |
| 2 July 2026 | Keybanc | Initiates | Overweight | $30 |
| 20 May 2026 | Barclays | Maintains | Overweight | — |
| 5 May 2026 | Citigroup | Maintains | Buy | — |
| 30 Apr 2026 | JP Morgan | Maintains | Overweight | — |
| 30 Apr 2026 | Needham | Reiterates | Buy | — |
| 30 Apr 2026 | UBS | Maintains | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. WAY appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 3 Sept 2026, Waystar Holding Corp. returned −30.5% against +21.4% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 21% of US stocks
Cheaper than 30% of US stocks
Cheaper than 65% of US stocks
Cheaper than 24% of US stocks
Higher than 67% of US stocks
Higher than 64% of US stocks
Higher than 82% of US stocks
Higher than 83% of US stocks
Higher than 72% of US stocks
Higher than 51% of US stocks
Higher than 68% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Waystar Holding Corp. has a market value of $5.0B and an enterprise value of $6.2B.
Revenue in the twelve months to 30 June 2026: $1.2B. The latest quarter grew 18.1% year on year.
Net income over the same four quarters: $134.8M, a 11.2% net margin.
Diluted earnings per share, trailing twelve months: $0.70.
Free cash flow in the twelve months to 30 June 2026: $246.3M.
Trailing P/E: 37.3×; forward P/E: 13.9× — the forward figure prices analyst consensus estimates, not reported earnings.
Waystar Holding Corp. employs 1,700 people — $709K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Waystar Holding Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Seeking Alpha published a transcript of Waystar Holding Corp.'s (WAY) Analyst/Investor Day. The item provides a record of remarks made during the company's investor-facing event.
Why it matters — A WAY watcher can review the transcript for management commentary and details presented directly to analysts and investors.
Waystar announced new agentic capabilities powered by its AltitudeAI platform that autonomously execute actions across revenue cycle workflows, advancing the company's vision for an autonomous revenue cycle. The company describes the tools as connecting intelligence to action for healthcare providers.
Why it matters — The launch signals Waystar's expansion into autonomous, AI-driven revenue cycle capabilities, which could broaden its healthcare payment software offering.
At its inaugural Investor Day in San Antonio, Waystar outlined a strategy to expand its healthcare revenue-cycle-management platform through artificial intelligence, automation, and broader adoption of its end-to-end product suite.
Why it matters — WAY watchers would care because the company is signalling its growth direction and product strategy to investors for the first time at a dedicated investor event.
Waystar announced two executive leadership appointments aimed at accelerating innovation, client adoption, and durable growth. The new hires bring world-class technology expertise and commercial leadership to advance the company's vision for the autonomous revenue cycle.
Why it matters — A WAY watcher would care because strengthened executive leadership in technology and commercial roles may support the company's growth strategy and innovation in healthcare payment software.
Waystar (WAY) has been upgraded to a Zacks Rank #2 (Buy), reflecting increased optimism about its earnings prospects. Zacks suggests this could drive the stock higher in the near term.
Why it matters — A Waystar watcher would care because the upgrade signals growing analyst confidence in the company's earnings outlook, which could influence investor sentiment and share performance.
The 24 Wall Street analysts covering Waystar Holding Corp. have a median 12-month price target of $33, with estimates ranging from $27 to $44. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 24 analysts covering Waystar Holding Corp., 23 rate it a Buy, 1 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Waystar Holding Corp. 38 out of 100 across roughly 4,600 US stocks as at 2 Sept 2026. None of this is personal advice — it does not consider your circumstances.
As at 2 Sept 2026, Waystar Holding Corp. ranks 38 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Revisions (81 of 100).
No one can know that. What the data says: the median 12-month target from 24 analysts implies +26.7% from the last close, and Ticker Nerd's factor model ranks Waystar Holding Corp. 38 out of 100 as at 2 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Waystar Holding Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for WAY are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $27 to $44 over the next 12 months.
Waystar Holding Corp. returned -30.5% over the 12 months to 3 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.
Waystar Holding Corp. is a healthcare technology company that provides cloud-based software for healthcare payments and revenue cycle management.
The most recent item we track (Seeking Alpha, 26 Aug 2026): "Waystar Holding Corp. (WAY) Analyst/Investor Day Transcript". Seeking Alpha published a transcript of Waystar Holding Corp.'s (WAY) Analyst/Investor Day. The item provides a record of remarks made during the company's investor-facing event.
Waystar Holding Corp. is a healthcare technology company that provides cloud-based software for healthcare payments and revenue cycle management. Waystar’s platform helps providers, clinics, hospitals, laboratories, and health systems manage financial clearance, eligibility checks, prior authorization, claims submission, payer remittances, denial prevention, recovery, and patient financial care. The company also offers analytics, reporting, and automated workflow tools designed to improve claim accuracy, strengthen data integrity, reduce manual administrative tasks, and support more efficient reimbursement processes. Its software is used across the care continuum by organizations of varying sizes, making Waystar a key provider of mission-critical payment technology in the healthcare sector.
CEO Mr. Matthew J. Hawkins · 1,700 employees · United States · https://www.waystar.com
